Xarelto (rivaroxaban) is a brand-name drug that helps treat or lower the risk of blood clots and certain other conditions. Xarelto comes as an oral tablet and suspension. The dosage can vary depending ...

The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto, which brought in nearly $2.4 billion in US sales last year. The US regulator has cleared 2.5mg ...

Lupin has received the Food and Drug Administration’s green light for rivaroxaban tablets, in 10 mg, 15 mg and 20 mg, which is the generic of Janssen’s Xarelto. This product will be manufactured at ...

Pexidartinib is an oral small molecule that is believed to work by inhibiting colony stimulating factor-1 receptor (CSF1R). Both doses of Xarelto (10mg and 20mg) were superior to aspirin (100mg) in ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for rivaroxaban ...

XARELTO (rivaroxaban) 20mg tablets Results of a study conducted by Janssen show that prothrombin complex concentrates can reverse the blood thinning effects of Xarelto (rivaroxaban) in healthy ...

Xarelto is a brand-name prescription medication approved to treat or help prevent harmful blood clots in certain adults and children. A program called the Xarelto withMe Savings Card may be available ...

The use of warfarin reduces the rate of ischemic stroke in patients with atrial fibrillation but requires frequent monitoring and dose adjustment. Rivaroxaban, an oral factor Xa inhibitor, may provide ...

With this, Aurobindo Pharma’s cumulative USFDA approvals now stand at 540, including 521 final approvals and 19 tentative ones. Aurobindo Pharma has received final approval from the US Food and Drug ...

The approval is only for the 2.5mg tablet. The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with aspirin, ...